The immunosuppressive drug rapamycin has been shown to increase longevity in mice even when treatment begins at an advanced age. It is unclear if the extension of life also correlates with prolonged health and vigor.
Jul 25, 2013
1
0
(Medical Xpress)—In the first step toward animal-to-human transplants of insulin-producing cells for people with type 1 diabetes, Northwestern Medicine scientists have successfully transplanted islets, the cells that produce ...
Jul 12, 2013
1
0
Two novel susceptibility genes to Takayasu Arteritis have been identified by a research group from the Department of Rhematology and Clinical Immunology, Kyoto University Graduate School of Medicine. This study was published ...
Jul 8, 2013
0
0
Analysis of three biomarkers in the urine of kidney transplant recipients can diagnose—and even predict—transplant rejection, according to results from a clinical trial sponsored by the National Institute of Allergy and ...
Jul 3, 2013
0
0
(Medical Xpress)—A single systemic dose of special immune cells prevented rejection for almost four months in a preclinical animal model of kidney transplantation, according to experts at the University of Pittsburgh School ...
Jun 28, 2013
0
0
More people are being affected by drug-induced liver injury (DILI) than ever before, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. This type of liver injury ...
Jun 26, 2013
0
0
Too much sugar can set people down a pathway to heart failure, according to a study led by researchers at The University of Texas Health Science Center at Houston (UTHealth).
Jun 14, 2013
0
0
The world's first double-leg transplant patient has had both limbs amputated after an unrelated illness forced him to stop taking anti-rejection drugs, the Spanish hospital that carried out the operation said Tuesday.
Jun 11, 2013
0
0
Researchers at Lund University in Sweden have discovered how to stop the destructive process that leads to cardiovascular disease in diabetic laboratory animals.
Jun 5, 2013
0
0
Patients with rheumatoid arthritis (RA) who initiated use of anti-tumor necrosis factor therapies were not at a higher risk of developing herpes zoster (shingles), compared with patients who initiated nonbiologic treatment ...
Apr 19, 2013
0
0
